Navigation Links
Newer Drugs Beat Gleevec in Head-to-Head Trials
Date:6/5/2010

More chronic myeloid leukemia patients responded to Sprycel and Tasigna than Gleevec

SATURDAY, June 5 (HealthDay News) -- Two new drugs, dasatinib (Sprycel) and nilotinib (Tasigna), appear better than imatinib (Gleevec) in treating patients with newly diagnosed chronic myeloid leukemia and should be considered as first-line treatments, two new studies show.

The findings, which should change clinical practice, are to be presented Saturday at the American Society of Clinical Oncology annual meeting in Chicago and were simultaneously published online June 5 in the New England Journal of Medicine.

"Both next-generation inhibitors of BCR-ABL [dasatinib and nilotinib] are superior to Gleevec in treating chronic myeloid leukemia when compared head-to-head after one year of follow-up," said Dr. Charles L. Sawyers, chair of the Human Oncology and Pathogenesis Program at the Howard Hughes Medical Institute at Memorial Sloan-Kettering Cancer Center in New York City and author of an accompanying journal editorial.

"This magnitude of success -- beating a drug like imatinib [Gleevec] that was already pretty great -- is possible because we have a very precise understanding of the drug target BCR-ABL and of the mechanisms of resistance to imatinib," Sawyers added.

Newly diagnosed chronic myeloid leukemia patients should probably now be treated with one of the new drugs instead of imatinib, he noted.

In the first study, a team led by Dr. Hagop Kantarjian, chairman of the leukemia department at the University of Texas M.D. Anderson Cancer Center in Houston, randomly assigned 519 patients to Sprycel or Gleevec.

After a year, 77 percent of the patients receiving Sprycel had a complete cytogenetic response, compared with 66 percent of the patients receiving Gleevec, the researchers found.

Complete cytogenetic response is the disappearance of all the cancer cells from the bone marrow, Kanta
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan
2. Newer Drug More Effective in Psoriasis Treatment
3. Newer cornea transplant surgery shows short- and long-term promise
4. Newer Blood Test Predicts Diabetes, Heart Disease
5. Newer Genetic Test for Autism More Effective
6. Newer Blood Thinner Beats Plavix for Bypass Patients
7. Newer Genetic Info Adds Little to Predicting Breast Cancer
8. In infant heart surgery, newer technique yields better survival in first year of life
9. New Drugs, New Combinations Fight Breast Cancer
10. NICE guidelines ration affordable osteoporosis drugs
11. Bone Drugs May Beat Back Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Plains, NJ (PRWEB) March 31, 2015 Dr. ... On March 19th, Dr. Parvez conducted Grand Grounds Presentations ... on “Prescribing Opioids and Managing Side Effects”. The event ... attending physicians. She received very positive feedback from the ... of the best that they’ve had in a while. ...
(Date:3/31/2015)... of the most beautiful and awe-inspiring aspects of a Hawaiian dream ... island. The big island of Hawaii, after all, is one ... oozing at your feet in one of the most sought after ... never expect to see a live volcano spewing ash and lava ... now. , Members of a local and independently owned Gold’s Gym ...
(Date:3/31/2015)... BESLER Consulting today announced the publication ... an Independent Cost Report Review.” , The Medicare ... in the determination of Medicare reimbursement to hospitals ... review, this report can assist management in future ... white paper discusses:,     The anatomy ...
(Date:3/31/2015)... Array Health , a leading provider of ... Hood, Senior Director of Marketing, will present at The ... 1, 2015. The session, co-presented with Brian Ridder, Vice ... can streamline and simplify the private exchange shopping, enrollment ... and Employer Needs in a Private Exchange – From ...
(Date:3/31/2015)... 31, 2015 More than 120 of ... to express their shared support for the same basic ... a 'True Health Coalition' and a lifestyle medicine initiative ... help demonstrate that, despite appearances to the contrary, there ... about the theme of healthful eating and living. ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3Health News:Array Health’s Senior Director of Marketing to Co-Present with Benaissance at The Institute for HealthCare Consumerism Private Exchange Forum 2Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 2Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 3Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 4
... TUESDAY, Jan. 25 (HealthDay News) -- Epilepsy was the likely ... Chopin, according to a new study. Researchers reached the ... musician,s own descriptions of his hallucinations -- including his description ... of his life written by pupils and friends such as ...
... Reinberg HealthDay Reporter , TUESDAY, Jan. 25 (HealthDay ... the U.S. Food and Drug Administration is asking an expert ... held to stricter standards. Over the past five years, ... used to shock a patient in cardiac arrest in hopes ...
... investigation and a blood test to measure the level of ... heart failure following acute coronary syndromes. This is the conclusion ... Acute coronary syndromes, such as myocardial infarction and unstable ... care and death in Sweden for both women and men. ...
... the AACR 102nd Annual Meeting 2011 is Friday, Feb. 25. ... editors and reporters, and we cannot guarantee that housing will ... will feature the latest findings in laboratory, translation and clinical ... meeting, including: nicotine supplements and tumor growth ...
... human immunodeficiency virus (HIV) impaired results of transplant ... patients dropping off the transplantation wait list. The ... was not impacted following liver transplantation in patients ... center studythe largest to dateare published in the ...
... studied the defences used by caterpillars that transform into ... regurgitate semi-digested cabbage leaves to make them smell and ... that frequent use of this defence reduces the caterpillars, ... It remains unclear why their defences affect them ...
Cached Medicine News:Health News:FDA Looking for Tougher Standards for External Defibrillators 2Health News:Ultrasound and a blood test can increase survival after myocardial infarction 2Health News:The American Association for Cancer Research hosts its 102nd Annual Meeting 2Health News:Patients infected with HIV have higher drop-out rate for liver transplantation 2Health News:Insects that deter predators produce fewer offspring 2
(Date:3/31/2015)... , March 31, 2015  The efficacy of continuous ... in a recently published study 1 of ultraviolet ... research team, including Curtis Donskey , M.D.  The ... for the same length of time from the same ... unit.  The results showed surprisingly low pathogen kill rates ...
(Date:3/31/2015)... According to a new ... Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, ... Centrifuge) - Global Forecast to 2019", published by ... Market is expected to reach $48.84 Billion by ... 2019. Browse   9 ...
(Date:3/31/2015)... Calif. , March 31, 2015  Frequentz Inc., ... has released a white paper to help the pharmaceutical ... 2013 Drug Supply Chain Security Act (DSCSA). The white ... stages of the GS1 EPCIS Standard(s) and ... outlook on the product tracing requirements that need to ...
Breaking Medicine Technology:VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3
... Causing Mitochondrial Disease More Common Than Previously,Believed, ... (UMDF) today announced landmark research finding that,one in ... could potentially cause a,mitochondrial disease in them or ... fatal disease, and mitochondrial disorders are at,the core ...
... Sanofi-aventis,(EURONEXT: SAN and NYSE: SNY) announced today ... priority review status for its New Drug,Application (NDA) ... July 31, 2008., The priority review is ... new drug product, if approved, has the potential ...
Cached Medicine Technology:New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease 2New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease 3Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation 2Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation 3
... designed to optimize the accuracy and precision ... products is widely recognized by customers throughout ... extended over the years and now covers ... tips including filter tips, certified pure tips, ...
... Processor is a primary component of an ... processing, sampling, and slide preparation all ... MonoPrep LBP Processor produces high-quality sample slides ... range of cytology specimen types. It processes ...
... innovative, quick and easy automated refill ... less space on your laboratory bench ... amazingly easy-to-use, one-hand system, you only ... range of Diamond Tips. All sizes ...
200 L, Racked, Pre-sterilized, 96 tips/rack, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
Medicine Products: